Office of Technology Transfer and Development

I.D.

Technology

Pat. No.
(LINK TO USPTO)

AM-004

Use of Synthetic Peptides to Disrupt the Cytoskeleton

5,527,773

AM-008

Engineering Protein Complexes to Display Massively Multimeric Antigens and Enzymes

AM-009

Laser Inducible Promoter System (LIPS)

AM-011

A Novel Method for Infectivity of Non-infectable Cells by the Semiliki Forest Virus

AM-012

Identification of the Gene Causing Familial Mediterranean Fever

AM-013

Inhibition of IL-6 mRNA production

AM-015

Automated dideoxy-fingerprinting for mutation detection

AM-016

Janus Family Kinases and Identification of Immune Modulators

AM-017

Synthesis and secretion of active recombinant lysosomal enzymes in the liver

AM-020

Deacetylase inhibitors as tools to promote cell differentiation and regeneration

DC-002

Synthesis of Lipooligosaccharide based vaccines for prevention of Moraxella

DC-003

Synthesis of lipooligosaccharide based vaccines for prevention of Neisseria meningitis

DC-005

Induction of cell death in breast cancer cells by anti-TRAIL R2/DR5 antibody

DC-007

Human genetic Variants causing inability to taste bitter substances

DC-008

Mechanosensory ion trnsduction channel of hair cells in inner ear

DC-011

Human Taste Receptor Variants

DC-012

Cloning of cDNAs encoding Human gastrin-releasing peptide receptor (GRP-R)

EH-001

Diagnostic Methods and Gene Therapy Using Reagents Dereived from the Human Metastasis Suppresor Gene KAI-1

EH-002

Mutants Having a Deficit of Functional Steroid Hormone Receptors

5,650,550

EH-004

"BRCA1 Functionally Null Cell Lines, A17T and A19T"

EH-005

V-ha-ras transgenic Tg.Ac mouse as a model for photocarcinogenesis

EH-007

ZZ-1 A Binding Partner for Steroid Receptors

EH-008

An E. Coli System for Isolation of Human and other Genes on the Basis of Induction of the SOS Response

EH-009

Human Lactoferin and Uses Thereof

EH-011

Human Meiosis Expressed

EH-012

Ultraselective Opiodmimetic Peptides and Pharmacological and Therapeutic Uses Thereof

ES-011

Human Meiosis Expressed Cyclin A1 in yeast

ES-012

Ultraselective Opiodmimetic Peptides and Pharmacological and Therapeutic Uses Thereof

ES-013

Laboratory Data Acquisition System (LDAS)

ES-014

A method for selective cloning of a targeted human chromosome region in yeast

ES-015

The use of gamma glutamyl transpeptidase related enzyme (GGT-rel) in the diagnosis and treatment of human lung cancer

ES-017

Radial trnsformation associated recombination cloning (TAR cloning)

ES-018

The use of cardiac glycosides to modulate the effect of apoptosis inducing drugs

ES-019

17Q Linked Breast and Ovarian Cancer Susceptibiity Gene

ES-020

Construction of cDNAs related to purification and characterization of DNA polymers

ES-021

Use of fluid phase endocytosis in screening for insulin-mimetic and insulin-potential compounds

ES-022

Apoliopoprotein E and regulation of response to cell injury and inflammation

ES-023

CCCH proteins as direct binding and stabilizing agents from Tumor Necrosis Factor Alpha mRNA

ES-024

Protein phosphatase inhibitors to up-regulate salt and fluid secretion in the lung of cystic fibrosis patients

ES-025

FXR activation by bile acids and substances that suppress cell growth

ES-026

The application of protein phosphatase inhibitors to up-regulate salt and fluids in CF patients

ES-027

Cardiac relaxation by pharmacological stimulation of Kach potassium channels

ES-029

Fluorescent Magnesium Indicators

ES-030

Novel Gene Family for the DiphosphoInositol Polyphosphate Phosphatases (DIPPs)

ES-031

Cloning Expression and Diagnosis of Human Cytochrome P450 2C19

ES-032

Tristetraprolin(TTP) inhibitors as agents to stabilize granulocyte-macrophage

ES-033

Method for Modulating Processses Mediated by Farnesoid Activated Receptors

ES-034

Targeting of human genes in chicken B cell hybrids containing human chromosomes

ES-035

Pharmaceutical Compositions Comprising Clozapine and a Radical Scavenger

ES-036

A genetic system in yeast for functional indentification of human p53 mutations

ES-037

A genetic system in yeast for turning p53 mutant protein into a toxin

ES-038

Compositions Comprising Vitamin F

ES-039

Anti-Inflamatory Properties of Cytochrome P450 Expoxygenase-Derived Eicosanoids

ES-040

Structured combinatorial queries for characterizing and comparing biological sequence

ES-042

Soluble Epoxide Hydrolase Inhibitors as Novel Therapeutic Agents for Management of Hypertension

ES-043

Wild -Type and DNA Polymerase B Null (KO) Mouse Embryonic Fibroblast Cell Lines

ES-044

Distabilizing agents for mRNAs containing AU-rich regions

ES-045

Inhibition of human multidrug resistance P-glycoprotein 1 by hybdrophobic analogs of the delta-opioned antagonist

ES-046

DMT-TIC DI and Tri-peptidic derivatives and related compositions and methods of use

ES-047

Use of Endogenous Vertebrate Phytase to Increase Capacity to Utilize phytic Acid in livestock feed

ES-048

A Non-Steroidal Anti-Inflammatory Drug related Gene (NAG-1) and secreted Protein with anti-tumorgenic properties

ES-049

Pharmaceutical Compositions Comprising Clozapine and a Radical Scavenger

ES-050

Gamma-glutamyl transpeptidase inhibitor

ES-051

A Forward Mutational Assay for Use with PhiX174 Transgenic Mice

ES-052

Kits for determining genotype and / or LOH at the SSLP loci in hybrid study animals

ES-053

Methods for the identification of textual and physical structured query fragment

ES-054

A versatile system for in vivo site-directed mutagenesis with oligonucleotides

ES-057

Pedigree Disequillibrium Test (PDT)

ES-058

Conversion of a potent opiod receptor antagonist into a potent agonist and other related opiod ligands

ES-060

Genetic engineering the nuclear orphan receptor to confer the drug-responsiveness

ES-063

Improved therrapy for asthma, bronchitis andy cystic fibrosis through altered expression of 1- phosphatase activity

ES-064

A novel RFXZ4 transcript for use in the diagnosis and prevention of familial congenital hydrocephalus

ES-065

An Isolate of Milk Thistle with Potential Anti-prostrate Cancer and Anti-cholesterol activity

ES-066

Mouse model for early onset cataract.

ES-067

Effective activation of poly(A) - specific ribonuclease (PARN) by tristetraproli (TTP) and related proteins

ES-068

Expression predictor

ES-069

Juvenile hormones and other insecticides modulate ecdysone receptor-dependent transcriptional activity

ES-070

Concept for Development of a Molecular Expression Knowledge Base

ES-071

Creating a Knowledge Management System on Environmental Gene Changes (EGC)

ES-072

Immortalization of human uterine leiomyoma (fibroid) and uterine smooth muscle

HL-005

Human Cells Implanted in Non-Human Animals

5,238,683

HL-017

Cross Axis Synchronous Flow- Through Coil Planet Centrifuge Free of Rotary Seals

4,714,554

HL-062

Retroviral Vectors Containing Internal Ribosome Entry

HL-075

A Simple Method To Form A Sharp Elution Peak Of A Target Solute By Adding A

5,354,473

HL-080

ADP-ribosylarginine Hydrolase Clone (Mammalian)

HL-081

Mammalian Muscle NAD: Arginine ADP-Ribosyltransferase

5,834,310

HL-098

Therapeutic Inhibition of Platelet Aggregation By Nucleophile-Nitric Oxide Comp

5,185,376

HL-100

Parvovirus B19 Receptor and Parvovirus B19 Detection

5,449,608

HL-101

A Mammalian Guanine Nucleotide-Binding Protein With An ADP-Ribosylation Factor

5,386,021 & 5,514,600

HL-110

Methods for Diagnosis of XSCID and Kits Thereof

5,518,880

HL-112

Increasing the Frequency of Homologous Recombination

HL-116

Adenovirus Mediated Augmentation of Cell Transfection With Unmodified Plasmid Vectors

HL-121

Vector Systems For The Generation of Adeno- Associated Virus Particles

HL-122

Fusion Proteins Containing Adeno-Associated Virus Rep Protiens

HL-123

T-Cell Alloantigen TR6.2 is an NAD Glycohydrolase

HL-126

Use of Growth Factors to Promote Myocardial Blood Vessel Growth

HL-132

VP1 Unique Region Peptides as Parvovirus Antigens

HL-142

Immunosuppression by inhibiting JAK3-IL-2 receptor association

6,265,160

HL-154

Constitutive Jak-Stat pathway in HTLV-I Transformed T-Cells

HL-157

A Lymphocyte ADP-Ribosyltransferase

HL-158

The Use of Lectin Cholestryl Acetyltransferase (LCAT) in the Treatment of Atherosclerosis

HL-159

Increased Expression of Alpha1-Antitrypsin in Expression Vectors

5,439,824

HL-168

A Lymphocyte ADP-Ribosyltransferase

HL-189

Inhibition of PrKX, a Novel Protein Kinase, and the cAMP-Dependent Protein Kinase

HL-202

Chromatographic Fractionation of Proteins by Ammonium Suflate Precipitation

HL-203

Nmi is a cofactor for STAT-dependent signaling

HL-207

Cloning of the human nuclear receptor co-repressor gene

HL-214

Discovery of a novel human aminopeptidase which may regulate cleavage and shedding

HL-218

HCDS1 kinase activates breast tumor suppressor BRCA1 and promote DNA damage repair

HL-222

Biotinylated y-glutmyl-cystinyl-glycine (glutathione) ethyl ester (Bio Gee)

HL-223

A Liver-specific ATP-Binding Tranporter Gene (WHITE3) is putative transporter

HL-234

Targeted T Cells Therapy For Human Leukemia: PR1 Peptide-Stimulated T Cells Selectivity

HL-235

Cardiac contraction is optimized through differential phosphorylation of myosin

HL-236

Cloning of a New Murine Type I cytokine Receptor.

HL-238

Identification and purification of pulmonary hypertensive substance from Group B streptoccus

HL-239

Labeling of atherosclerotic plaques with anti-cholesterol monoclonal antibodies.

HL-241

Fanconi Anemia Protein Complex is a Target of the IKK Signalsome

HL-244

Recombinant Mouse Magnesium-Dependent Phosphatase -1(MDP-1)

HL-249

A selenium containing derivative of lipoic acid.

HL-250

Nitric Oxide Inhalation for Improvement in Blood Flow (Tissue Perfusion) in Patients

HL-251

Monoclonal antibody recognizing the iron regulatory protein-2 (IRP-2)

HL-255

A method for identifying genes determining cellular phenotypes and expression

HL-256

The discovery of a population of stem cells in adult murine skeletal muscle

HL-261

The G protein coupled receptor FPRLI as a target for developing therapeutic agents

HL-265

Modified defensins as therapeutic agents in inflammatory diseases

HL-266

Novel mammalian selenium-containing protein

HL-269

Tryptophan as a Functional replacement for ADP-ribose arginine in recombinant proteins

HL-272

IL 21 critically regulates immunoglobulin production

HL-273

Intralumenal toxin binding by factors derived from natural products.

HL-275

Identification of proteins using molecular weight and accurate aromatic amino acids

HL-276

Method for the preparative separation of polar compounds

HL-277

Compositions and methods for inhibiting Group B streptococcus-induced pulmonary disease

HL-278

Detection of mutational frequency in human bone marrow by sequencing of mitochodria

HL-284

Protein knockout by controllable RNAi in cells and animals

HL-285

Endothelial progenitor cells for the diagnosis and treatment of vascular disease

All inquires should be directed to (301)-402-5579